Skip to main content
Smart Investors Daily
ST

NASDAQ · STRNY

Severn Trent Plc

Utilities · Regulated Water

$41.30

Up+$0.39 (+0.95%)

Updated Sep 26, 2026, 7:32 AM

SID Score

5.8/10

Composite research score

Smart Money

46/100

Neutral

Market cap
11B
P/E ratio
25.6
Dividend yield
3.97%
52-week range
— – —
Volume
7.26K
Avg. volume
21.1K

Price performance

STRNY price history

1M range · 0 trading sessions · Daily adjusted prices

STRNY does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest STRNY news

The latest Smart Investors Daily articles mentioning STRNY.

STRNY research

Overview

Company profile and research snapshot.

Company profile

SEVERN TRENT PLC SPON/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$40.71
Implied upside
—
Analysts
22
STRNY recent ratings
DateFirmRatingTarget
Jun 11, 2026CitigroupNeutral—
Jun 1, 2026RBC Capital MarketsSector Perform—
May 21, 2026DeutscheHold—
May 21, 2026JefferiesBuy—
May 18, 2026UBSSell—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Sep 3, 2026

Diversified Energy, Galliford Try, Sunda Energy, Rockfire Resources, Solvonis Therapeutics, Futura

Diversified Energy Company PLC (LSE:DEC, NYSE:DEC, FRA:DG20) has agreed its biggest-ever deal, paying $1.8 billion for Permian Basin producer Birch. It should boost production by around 35%. Galliford Try Holdings PLC (LSE:GFRD, FRA:3WC) has landed a £110 million contract to improve water quality in the River Mease. It'll build a 23-kilometre pipeline for Severn Trent. Sunda Energy PLC (AIM:SNDA, FRA:GHA0) has seen a big upgrade at its Halcon prospect offshore the Philippines, now assigned 8 trillion cubic feet of gas resources. That gives Sunda a 3 Tcf net share. Rockfire Resources PLC (LSE:ROCK) says early processing tests at its Molaoi zinc project in Greece look promising. The ore's classed as "Medium-Hard," sitting comfortably within normal grinding energy requirements. Solvonis Therapeutics PLC (LSE:SVNS, OTC:SLVNF) has been granted a key European patent allowance for its PTSD drug candidate SVN-114. The company calls it a "vital milestone" strengthening its IP position. Futura Medical PLC (AIM:FUM, OTC:FAMDF, FRA:GYX) has kicked off a formal sale process for the business behind its Eroxon gel. It's also raised £1.6 million to fund the process through to a decision. Follow us and subscribe on YouTube, our social channels, and on proactiveinvestors.co.uk.

Yahoo · Jun 17, 2026

Severn Trent (LSE:SVT) Stock Fair Value Edges Lower As Analysts Split On Targets

Price target moves around Severn Trent are relatively modest, with fair value in one updated model trimmed from £32.12 to £31.69. That aligns with a wider mix of analyst views, where targets span roughly 2,879 GBp to 3,500 GBp as opinions differ on how confidently to price the company’s execution and risk profile. Read on to see what is driving these shifts and how to keep track of the evolving Severn Trent story as new information emerges. Stay updated as the Fair Value for Severn Trent...

Yahoo · Feb 19, 2026

Looking At The Severn Trent LSE SVT Story After Mixed Rating Shifts

The latest update on Severn Trent edges the fair value estimate to £30.22 per share versus £30.20 previously, with a discount rate of 7.20% compared with 7.07% and long term revenue growth assumptions held at 9.89%. This small tweak reflects a balance between recent research upgrades that support the earnings outlook and a more cautious stance from others who highlight sensitivity to the discount rate and regulatory decisions on growth. Stay tuned to see how you can track these kinds of...

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.